NCT04111081

Brief Summary

Auricular pressure is effective for postoperative analgesia after hemorrhoidectomy, but the evidence is not sufficient.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

February 18, 2020

Status Verified

February 1, 2020

Enrollment Period

1.3 years

First QC Date

September 17, 2019

Last Update Submit

February 15, 2020

Conditions

Keywords

hemorrhoidectiomypostoperative painauricular pressure

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale(VAS)

    It is a unidimensional measure providing a simple solution for measuring subjective experience. The VAS scale is a 10-cm line with 0 cm indicating no symptoms and 10 cm indicates the greatest extent of symptoms. Twenty-four hours after the operation, VAS\>3 in the case of an analgesic pump can be included in the randomized control group.

    Day 1 after randomization.

Secondary Outcomes (3)

  • Hospital Anxiety and Depression scale(HAD)

    Twenty-four hours, three days, and seven days after surgery

  • The utilization rate of analgesic drugs(Diclofenac Sodium Dual Release Enteric-coated Capsules)

    Day 7 after randomization.

  • Amount of analgesic drugs (Diclofenac Sodium Dual Release Enteric-coated Capsules)

    Day 7 after randomization.

Other Outcomes (1)

  • Tissue edema

    Day 3, day4, day5, day6 and day7 after randomization.

Study Arms (2)

Auricular pressure

EXPERIMENTAL

Use wangbuliuxing seed to stimulate auricular acupuncture point.

Other: Auricular pressure

Sham auricular pressure

SHAM COMPARATOR

Use wangbuliuxing seed to stimulate auricular acupuncture point.

Other: Shame auricular pressure

Interventions

Select related auricular points: Shenmen(TF4), sympathetic(AH6a), rectum(HX2), anus(HX5), stomach(CO4), subcortical(AT4). The auricle skin of the patient was disinfected 24 hours after the operation, and wanghuoxing seed will be used for stimulation. Ask patients press every two hours for one minute at each point. When the pain is severe, do pressure compressions at each point for 2 minutes once hour.

Auricular pressure

Select unrelated auricular points: eye(LO5), occipital(AT3), tonsil(LO7,8,9), lower auricular root(R3), dorsum auricular kidney(P5) and dorsum auricular lung(P2). The auricle skin of the patient was disinfected 24 hours after the operation, and wanghuoxing seed will be used for stimulation. Ask patients press every two hours for one minute at each point. When the pain is severe, do pressure compressions at each point for 2 minutes once hour.

Sham auricular pressure

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet the diagnostic criteria of grade II-IV mixed hemorrhoids and meet the operation conditions;
  • Age 18\~65;
  • External stripping and internal ligation of mixed hemorrhoids, general anesthesia or lumbar shu point anesthesia;
  • VAS score ≥3 points after the implementation of analgesia pump;
  • Improve clinical auxiliary examination and sign informed consent.

You may not qualify if:

  • Combined with inflammatory hemorrhoids, thrombotic hemorrhoids, perianal eczema, perianal abscess and other perianal diseases that affect the evaluation of curative effect;
  • Combined with intestinal infectious diseases, intestinal polyps, rectal malignant tumors, etc;
  • Combined with severe cardiovascular disease, immune deficiency, mental disorder, or severe liver and kidney dysfunction;
  • Auricle skin lesions or auricle skin allergy to tape is difficult to tolerate treatment;
  • Combined cognitive impairment could not complete the efficacy; evaluation;
  • Pregnancy or planned pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chengdu University of Traditional Chinese Medicine

Chengdu, Sichuan, 610075, China

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Hui Zheng, PhD

    Chengdu University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2019

First Posted

October 1, 2019

Study Start

March 1, 2020

Primary Completion

July 1, 2021

Study Completion

July 1, 2021

Last Updated

February 18, 2020

Record last verified: 2020-02

Locations